CRBP
Corbus Pharmaceuticals Holdings, Inc.
$9.38
+0.38 (+4.22%)
At close · Jul 7
Market Cap
$176.94M
Shares
18,527,795
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2022
Net Income
-$78.54M
-95.3%
FY2025
Operating Margin
-6350.09%
-3230.9pp
FY2021
Diluted EPS
-$5.90
-60.3%
FY2025
Operating Cash Flow
-$64.49M
-54.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | $0 | $881.71K | $3.94M | $36.14M | $4.82M | $2.44M | $1.91M | $648.38K | — | — | |
| -$776.97K | — | — | -$2.92M | -$2.13M | -$1.83M | -$1.03M | $1.23M | — | — | — | — | — | — | |
| $74.27M | $70.1M | $32.22M | $31.17M | $16.14M | $36.45M | $98.27M | $89.6M | $48.61M | $26.04M | $15.44M | $5.89M | $1.26M | $210.67K | |
| $15.57M | $15.22M | $16.5M | $13.91M | $18.7M | $20.43M | $28.48M | $23.64M | $12.96M | $8.96M | $6.46M | $3.61M | $1.39M | $346.61K | |
| — | $233K | $588K | $641K | $763K | $999.82K | $1.12M | $739.38K | $493.94K | $255.65K | $87.66K | $43.94K | — | — | |
| $89.84M | $85.31M | $48.72M | $45.08M | $39.84M | $56.87M | $126.75M | $113.25M | $61.57M | $35M | $21.9M | $9.5M | $2.65M | $557.28K | |
| -$89.84M | -$85.31M | -$48.72M | -$45.08M | -$39.84M | -$55.99M | -$122.81M | -$77.1M | -$56.75M | -$32.56M | -$19.99M | -$8.85M | -$2.65M | -$557.28K | |
| — | — | — | — | — | -6350.09% | -3119.2% | -213.33% | -1176.78% | -1334.43% | -1045.56% | -1365.51% | — | — | |
| — | -$85.08M | -$48.13M | -$44.44M | -$39.07M | -$54.99M | -$121.69M | -$76.37M | -$56.25M | -$32.31M | -$19.9M | -$8.81M | — | — | |
| — | $0 | $1.87M | $3.86M | — | — | — | — | — | — | — | $2440 | $24.02K | $45.11K | |
| — | — | — | — | — | — | — | $1.23M | $982.78K | — | — | $3417 | $2115 | $754 | |
| $5.31M | $6.77M | $8.51M | $474K | -$2.51M | $10.35M | $11.54M | $5.65M | $1.08M | $141.2K | -$13.62K | $2954 | $106.69K | -$45.07K | |
| — | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | |
| -$84.53M | -$78.54M | -$40.21M | -$44.6M | -$42.35M | -$45.64M | -$111.27M | -$71.45M | -$55.67M | -$32.42M | -$20M | -$8.85M | -$2.54M | -$602.35K | |
| — | — | — | — | — | -5176.38% | -2826.08% | -197.69% | -1154.48% | -1328.65% | -1046.27% | -1365.05% | — | — | |
| — | -$78.54M | -$40.21M | — | — | — | — | — | — | — | — | — | — | — | |
| -$14.93M | — | — | — | — | — | — | — | — | — | — | -$8.85M | -$2.54M | — | |
| -$84.67M | -$78.63M | -$40.17M | -$44.48M | -$42.41M | -$45.7M | -$111.27M | — | — | — | — | — | — | — | |
| USD/shares | — | -$5.90 | -$3.68 | -$10.31 | -$10.15 | -$11.15 | -$42.60 | — | — | — | — | — | — | — |
| USD/shares | — | -$5.90 | -$3.68 | -$10.31 | -$10.15 | -$11.15 | — | — | — | — | — | — | — | — |
| shares | — | 13.32M | 10.92M | 4.33M | 4.17M | 4.09M | 2.6M | 2.13M | 1.9M | 1.67M | 1.37M | 1.05M | 672K | 232.16K |
| shares | — | 13.32M | 10.92M | 4.33M | 4.17M | 4.09M | 2.6M | 2.13M | 1.9M | 1.67M | 1.37M | 1.05M | 672K | 232.16K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.